Vaccination against invasive pneumococcal disease in Saudi Arabia: Where do we stand?

Annals of Saudi Medicine

Volumn 25, Issue 2, 2005, Pages 90-93

  Frayha, Husn H ^a   Al Mazrou, Yagob Y ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b MINISTRY OF HEALTH   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ANTIBODY RESPONSE; ARTICLE; BACTERIUM ISOLATE; CHEMOPROPHYLAXIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOCOMPETENCE; INFECTION PREVENTION; MASS IMMUNIZATION; MORBIDITY; MORTALITY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SAUDI ARABIA; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 18744372487     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2005.90     Document Type: Article

References (22)

1. Mckenzie H, Reid N, Dijkhuizen RS. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteraemia. J Med Microbiol. 2000;49:361-366.
2. Center for Disease Control and Prevention. Prevention of pneumococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1997;46(No-RR-8):1-24.
3. Center for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2000;49(RR-9):1-35.
4. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, Part I. Clin Infect Dis. 2000;30;100-21.
5. Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP): Pneumococcal Vaccination for Cochlear Implant Candidates and Recipients. MMWR. 2003;52(31): 739-40.
6. Al-Mazrou YY, Al-Jeffri MH, Al-Haggar SH, Musa EK, Mohamed OM,Abdalla MN. Haemophilus type b meningitis in Saudi children under 5 years old. J Tropical Pediatrics. 2004;50 (3):131-35.
7. Almuneef M, Memish Z, Khan Y, Kagallwala A, Alshaalan M. Childhood bacterial meningitis in Saudi Arabia. J Infect. 1998;36(2):157-60.
8. Al-Jurayyan NA, Al Mazyad AS, Al-Nasser MN, Al-Eissa YA, Abo-Bakr Arabia. Childhood bacterial meningitis in Al-Baha province, Saudi Arabia. J Trop Med Hyg. 1992;95(3):180-5.
9. Srair HA, Aman H, Al-Madan M, Al-Khater M. Bacterial meningitis in Saudi children. Indian J Pediatr. 1992;59 (6):719-21.
10. Kambal AM, and Abdullah AM. Childhood pneumococcal bacteremia in Riyadh, Saudi Arabia. Ann Trop Paediatr. 1997;17(3):245-51.
11. Al-Jurayyan NA, Al Mazyad AS, Al-Nasser MN, et al. Childhood bacterial meningitis in Al-Baha province, Saudi Arabia. J Trop Med Hyg. 1992;95(3):180-5.
12. Memish ZA, Balkhy H, Shibl AM, Barrozo CP, Gray GC. Streptococcus pneumoniae in Saudi Arabia: antibiotic resistance and serotypes of recent clinical isolates. Int J Antimicrobial Agents. 2004;23:32-38.
13. Al Mazrou A, Twum-Danso K, Al Zamil F, Kambal AM. Streptococcus pneumoniae serotypes/serogroups causing invasive disease in Riyadh, Saudi Arabia: extent of coverage by pneumococcal vaccines. Ann Saudi Med. 2005;25(2):94-99
14. Al-Tawfiq JA. Pattern of antibiotic resistance of Streptococcus pneumoniae in a hospital in the Eastern Province of Saudi Arabia. J Chemother. 2004;16(3):259-63.
15. El-Mouzan MI, Twan-Danso K. Al-Awamy BH, Niazi GA, Altorki MT. Pneumococcal infections in eastern Saudi Arabia: serotypes and antibiotic sensitivity pattern. Trop Geogr Med. 1988;40(3):213-7.
16. Al-Ageeli AA, Guy ML, Al-Jumaah SA. Streptococcus pneumoniae resistance to penicillin and ceftriaxone in a tertiary care center in Saudi Arabia. Saudi Med J. 2002;23(4):400-4.
17. Shibl AM, Al Rasheed AM, Elbashier AM, Osoba AO. Penicillin-resistant and intermediate Streptococcus pneumoniae in Saudi Arabia. J Chemother. 2000;12(2):134-7.
18. Eltahawy AT. Antimicrobial resistance of Streptococcus pneumoniae at a university hospital in Saudi Arabia. J Chemother. 2001;13(2):148-53.
19. Cornu C. Yzebe D. Leophonte P, et al. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine 2001;19(32):4780-90.
20. Black S. Lieu TA. Ray GT. Capra A. Shinefield HR. Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente. Vaccine. 2000;19 Suppl 1:S83-6.
21. Scheifele D. Halperin S. Pelletier L. Talbot J. Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT). Clin Infect Dis. 2000;31(1)58-64.
22. O'Brien KL. Swift AJ. Winkelstein JA, et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM (197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group. Pediatrics. 2000;106(5):965-72.